Antiviral drugs against herpes infections

Indian Journal of Pharmacology

Volumn 32, Issue 6, 2000, Pages 330-338

  Vajpayee, Madhu ^a   Malhotra, Neena ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acyclovir; Antiviral agents; Cidofovir; Famciclovir; Herpes infection; Herpes simplex; Penciclovir; Sorivudine; Valacyclovir; Varicella; Vidarabine; Zoster

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ALLOPURINOL; ANTIVIRUS AGENT; CIDOFOVIR; CIMETIDINE; CIPROFLOXACIN; CYCLOSPORIN; DIGOXIN; FAMCICLOVIR; FLUOROPYRIMIDINE DERIVATIVE; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; IDOXURIDINE; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; LOBUCAVIR; NETIVUDINE; PENCICLOVIR; PENTAMIDINE; PROBENECID; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERFERON; SORIVUDINE; THEOPHYLLINE; TRIFLURIDINE; UNINDEXED DRUG; VALACICLOVIR; VIDARABINE; VIRUS DNA;

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG TARGETING; ELECTROLYTE DISTURBANCE; EYE IRRITATION; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMATOLOGIC DISEASE; HERPES VIRUS INFECTION; HUMAN; INFECTION CONTROL; KIDNEY DISEASE; LIVER DISEASE; NEPHROTOXICITY; NEUROTOXICITY; REVIEW; VIRUS RESISTANCE;

EID: 0034519360     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Acyclovir: A decade later
2. Acyclovir versus vidarabine in herpes simplex encephalitis: Randomised multticentre study in consecutive Swedish patients
3. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection
4. Intravenous acyclovir treatment for primary genital herpes
5. A trial of topical acyclavir in genital herpes simplex virus infection
6. Recurrent genital herpes and suppressive oral acyclovir therapy
7. Acyclovir prophylaxis for herpes simplex virus infection
8. Two distinct loci confer resistance to acycloguanosine in herpes simplex type 1
9. A controlled trial comparing foscarnet with vidarbine for acyclovir resistant, mucocutaneous herpes simplex in aquired immunodeficiency syndrome
10. Valacyclovir: A review of its antiviral activity pharmacokinetic properties and clinical efficacy
11. Ganciclovir. A review of its antiviral activity pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infection
12. Ganciclovir. An update of its use in prevention of cytomegalovirus infection and disease in transplant recipients
13. Cytomegalovirus infection in patients with AIDS
14. Cytomegalovirus colitis in HIV infected patients: A prospective research in 55 patients
15. Antimicrobial strategies in the care of organ transplant recipients
16. Human cytomegalovirus UL 97 open reading frame encodes protein that phosphorylates the antiviral nucleoside analogue ganciclovir
17. Cytomegalovirus resistance to antiviral therapies
18. Progressive disease due to ganciclovir resistant cytomegalovirus in immunocompromised patients
19. Trisodium phosphonoformate, a new antiviral compound
20. Studies of Ocular complication of AIDS Research Group, in collaboration with the AIDS Clinical Trial Group: Mortality in patients with the acquired immunodefeciency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis
21. Concurrent use of ganiclavir and foscarnet to treat cytomegalovirus infection in AIDS patients
22. Isolation of foscarnet-resistant human cytomegalovirus patterns of resistance and sensitivity to other antiviral drugs
23. Successful treatment of progressive mucocutaneous infection due to acyclovir and foscarnet resistant herpes simplex virus with (s)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC)
24. Foscornet resistant herpes simplex virus infection in patients with AIDS
25. Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir
26. Sorivudine: A promising drug for the treatment of varicella-zoster virus infection
27. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication
28. Intracellular metabolism of the antiherpes agent (s)-1-[3-hydroxy-2(phosphanylmethoxy) propylcytosine
29. Clinical pharmacokinetic of cidofovir in human immunodeficiency virus infected patients
30. Treatment of anogenital papillomavirus infection with an acyclic nucleoside phosphonate analog
31. Current pharmacological approach to the therapy of varicella zoster infection - A guide to treatment
32. General aspects of drug resistance with special reference to herpes simplex virus
33. Trifluorothymidine versus adenine arabinoside in the treatment of herpes simplex keratitis
34. Topical trifluridine for mucocutaneous acyclovir resistant herpes simplex II in AIDS patients